𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony- stimulating factor: A phase I study with apparent activity in non-small-cell lung cancer


Book ID
122744478
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
273 KB
Volume
12
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase I/II study of carboplatin and oral
✍ Giuseppe Frasci; Giovanni Persico; Giuseppe Perillo; Giuseppe Comella; Pasquale πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 665 KB

Background. A combination of carboplatin (CBDCA) and oral etoposide is better tolerated than, and as effective as, more aggressive chemotherapy regimens in patients with advanced nonsmall cell lung cancer (NSCLC). A Phase 1/11 study was conducted to determine whether the addition of the granulocyte-